Compare CareRx Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 244 Million (Small Cap)
224.00
NA
0.00%
0.36
1.76%
2.80
Revenue and Profits:
Net Sales:
91 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.8%
0%
11.8%
6 Months
3215.11%
0%
3215.11%
1 Year
3361.2%
0%
3361.2%
2 Years
1821.74%
0%
1821.74%
3 Years
554.85%
0%
554.85%
4 Years
1120.13%
0%
1120.13%
5 Years
1520.04%
0%
1520.04%
CareRx Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.87%
EBIT Growth (5y)
61.23%
EBIT to Interest (avg)
0.46
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
2.52
Tax Ratio
0.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
4.21%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
224
Industry P/E
Price to Book Value
2.58
EV to EBIT
30.72
EV to EBITDA
9.56
EV to Capital Employed
2.11
EV to Sales
0.72
PEG Ratio
2.13
Dividend Yield
NA
ROCE (Latest)
6.86%
ROE (Latest)
0.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2016
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
91.40
89.60
2.01%
Operating Profit (PBDIT) excl Other Income
7.50
7.40
1.35%
Interest
1.80
1.80
Exceptional Items
-0.40
-0.50
20.00%
Consolidate Net Profit
0.60
0.20
200.00%
Operating Profit Margin (Excl OI)
32.00%
29.00%
0.30%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 2.01% vs -2.82% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 200.00% vs 109.09% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
366.70
370.70
-1.08%
Operating Profit (PBDIT) excl Other Income
26.60
27.20
-2.21%
Interest
9.20
15.60
-41.03%
Exceptional Items
-2.10
-2.10
Consolidate Net Profit
-4.50
-5.40
16.67%
Operating Profit Margin (Excl OI)
20.30%
19.50%
0.08%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -1.08% vs -2.88% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 16.67% vs 84.30% in Dec 2023
About CareRx Corp. 
CareRx Corp.
Pharmaceuticals & Biotechnology
CareRx Corporation (CareRx), formerly Centric Health Corporation, is a Canada-based provider of pharmacy services and solutions to home operators and residents. The Company offers a range of medication solutions. CareRx provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. The Company serves long-term care, retirement and assisted living, and supportive housing and group homes. CareRx offers a range of technology and program solutions, which includes eMAR Integration, Digital Prescribing, Nursing Portal and Karie Medication Dispenser.
Company Coordinates 
Company Details
20 Eglinton Ave W , TORONTO ON : M4R 1K8
Registrar Details






